Morgan Stanley’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225M Buy
1,479,050
+333,119
+29% +$55.5M 0.01% 962
2026
Q1
$240M Buy
1,145,931
+11,348
+1% +$2.85M 0.01% 851
2025
Q4
$322M Sell
1,134,583
-134,526
-11% -$42.1M 0.02% 706
2025
Q3
$392M Buy
1,269,109
+11,055
+0.9% +$3.46M 0.02% 614
2025
Q2
$395M Buy
1,258,054
+50,460
+4% +$14.6M 0.03% 587
2025
Q1
$317M Sell
1,207,594
-90,190
-7% -$24.4M 0.02% 636
2024
Q4
$339M Buy
1,297,784
+88,564
+7% +$22.3M 0.02% 616
2024
Q3
$281M Sell
1,209,220
-62,233
-5% -$12.8M 0.02% 672
2024
Q2
$257M Sell
1,271,453
-117,119
-8% -$21.1M 0.02% 688
2024
Q1
$238M Buy
1,388,572
+373,597
+37% +$69.7M 0.02% 710
2023
Q4
$220M Sell
1,014,975
-28,322
-3% -$4.86M 0.02% 726
2023
Q3
$166M Buy
1,043,297
+332,194
+47% +$74.4M 0.02% 781
2023
Q2
$205M Buy
711,103
+171,310
+32% +$52M 0.02% 705
2023
Q1
$172M Sell
539,793
-39,589
-7% -$11.7M 0.02% 758
2022
Q4
$171M Sell
579,382
-42,025
-7% -$11.6M 0.02% 759
2022
Q3
$143M Sell
621,407
-2,607
-0.4% -$653K 0.02% 728
2022
Q2
$136M Buy
624,014
+126,450
+25% +$28.7M 0.02% 757
2022
Q1
$133M Buy
497,564
+44,503
+10% +$10.9M 0.02% 704
2021
Q4
$121M Buy
453,061
+45,030
+11% +$13.1M 0.01% 782
2021
Q3
$116M Buy
408,031
+59,417
+17% +$16.9M 0.02% 764
2021
Q2
$95.7M Buy
348,614
+47,340
+16% +$12.9M 0.01% 871
2021
Q1
$78.6M Sell
301,274
-49,996
-14% -$13.4M 0.01% 898
2020
Q4
$89.8M Buy
351,270
+67,517
+24% +$16.8M 0.01% 777
2020
Q3
$67.1M Buy
283,753
+4,649
+2% +$979K 0.01% 768
2020
Q2
$54.2M Sell
279,104
-9,276
-3% -$1.77M 0.01% 804
2020
Q1
$47.8M Sell
288,380
-25,468
-8% -$4.65M 0.01% 760
2019
Q4
$53.7M Buy
313,848
+190,948
+155% +$31.8M 0.01% 885
2019
Q3
$20.3M Sell
122,900
-17,343
-12% -$2.44M 0.01% 1483
2019
Q2
$16.7M Buy
140,243
+26,225
+23% +$2.69M ﹤0.01% 1633
2019
Q1
$10.8M Sell
114,018
-11,664
-9% -$1,000K ﹤0.01% 1966
2018
Q4
$9.97M Buy
125,682
+972
+0.8% +$82.3K ﹤0.01% 2130
2018
Q3
$13.2M Sell
124,710
-226,107
-64% -$21.2M ﹤0.01% 2119
2018
Q2
$30.1M Buy
350,817
+96,995
+38% +$8.7M 0.01% 1262
2018
Q1
$22M Buy
253,822
+1,943
+0.8% +$151K 0.01% 1582
2017
Q4
$17.4M Buy
251,879
+110
+0% +$7.22K ﹤0.01% 1795
2017
Q3
$13.9M Buy
251,769
+40,588
+19% +$2.22M ﹤0.01% 1950
2017
Q2
$10.8M Sell
211,181
-281,301
-57% -$12.2M ﹤0.01% 2107
2017
Q1
$21.2M Sell
492,482
-195,181
-28% -$8.37M 0.01% 1501
2016
Q4
$25.9M Sell
687,663
-30,712
-4% -$1.14M 0.01% 1314
2016
Q3
$29.4M Buy
718,375
+33,125
+5% +$1.31M 0.01% 1173
2016
Q2
$20.7M Buy
685,250
+129,065
+23% +$4.02M 0.01% 1397
2016
Q1
$18.4M Sell
556,185
-210,060
-27% -$6.6M 0.01% 1365
2015
Q4
$29M Buy
766,245
+140,302
+22% +$4.72M 0.01% 1141
2015
Q3
$16.2M Buy
625,943
+365,186
+140% +$11.1M 0.01% 1557
2015
Q2
$8.08M Sell
260,757
-95,312
-27% -$2.81M ﹤0.01% 2330
2015
Q1
$11.9M Buy
356,069
+110,158
+45% +$3.72M ﹤0.01% 1895
2014
Q4
$11.3M Sell
245,911
-15,556
-6% -$665K ﹤0.01% 1944
2014
Q3
$9.63M Buy
261,467
+14,260
+6% +$521K ﹤0.01% 2051
2014
Q2
$9.81M Sell
247,207
-19,526
-7% -$750K ﹤0.01% 2050
2014
Q1
$12.6M Buy
266,733
+19,115
+8% +$846K 0.01% 1764
2013
Q4
$9.19M Buy
247,618
+3,121
+1% +$115K ﹤0.01% 2015
2013
Q3
$8.86M Buy
244,497
+17,669
+8% +$593K ﹤0.01% 1872
2013
Q2
$7.13M Buy
+226,828
New +$6.43M ﹤0.01% 1994

Other funds holding PODD

Morgan Stanley's PODD Position: Q2 2026 in Review

Morgan Stanley increased its Insulet (PODD) stake by 29% in Q2 2026, buying an estimated $55.5M and bringing the position to 1,479,050 shares worth $225M. The position accounts for 0.01% of the portfolio, ranked #962.

Morgan Stanley first reported a position in PODD in Q2 2013 and has held it in 53 quarters since. The position peaked at $395M in Q2 2025. 723 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Morgan Stanley held 1,479,050 shares of Insulet worth $225M as of Q2 2026.
  • Morgan Stanley bought 333,119 Insulet shares in Q2 2026, an estimated $55.5M.
  • Insulet made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #962 holding.
  • Morgan Stanley first reported a position in Insulet in Q2 2013 and has held it in 53 quarters since.
  • Morgan Stanley's Insulet position peaked at $395M in Q2 2025.
  • 723 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.